Gene · 11280
Papers1,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chasing the Wrong Door for 30 Years: Is Suzetrigine the Key to Selective Pain Relief? | Medicina (Kaunas) | 2026 | 42796305 | PubTator, text mining | PubMed |
| Cu Doping Activates SnS2 Basal Planes for Efficient CO2 Electroreduction to Formate. | Langmuir | 2026 | 42714836 | PubTator, text mining | PubMed |
| A designer saxitoxin-engineered sodium channel pair as a general tool for subtype-selective inhibition. | Cell Chem Biol | 2026 | 42679814 | PubTator, text mining | PubMed |
| Nonaddictive Analgesia: New Approaches That Target the Hodgkin-Huxley NaV/KV Dyad. | Annu Rev Pharmacol Toxicol | 2026 | 42594287 | PubTator, text mining | PubMed |
| New insight into RNA biomarkers in neuropathic pain: a clinician-neuroscientist roadmap to translational testing and treatment monitoring a clinical review. | Front Pain Res (Lausanne) | 2026 | 42534835 | PubTator, text mining | PubMed |
| Magnetoelastic Transport-Path Reconstruction and Giant Magnetotransport Responses in a Two-Dimensional Antiferromagnet. | Nano Lett | 2026 | 42503889 | PubTator, text mining | PubMed |
| Phase-Restructured SnS2 Nanodots: Unlocking ORR Activity through Thermal Stress-Mediated Fracturing. | Small | 2026 | 42434923 | PubTator, text mining | PubMed |
| Gate-Tunable Magnetoresistance in Antiferromagnetic van der Waals FePS3 Transistors. | Nano Lett | 2026 | 42407046 | PubTator, text mining | PubMed |
| Isoform-Specific NaV Modulation in Painful Chemotherapy-Induced Neuropathy: Promise, Limitations, and a Clinical Agenda. | CNS Drugs | 2026 | 42334794 | PubTator, text mining | PubMed |
| Selectivity Reversal from CO to Ethylene Products in CO2 Photoreduction via Electronic Modulation of SnS2 Using a Vinyl-Bridged Porous Organic Polymer. | J Am Chem Soc | 2026 | 42330158 | PubTator, text mining | PubMed |
| Quantum Confinement Effect in a Heteromorphic PbS/SnS2 Superlattice Grown by Atomic Layer Deposition. | ACS Nano | 2026 | 42274058 | PubTator, text mining | PubMed |
| Molecular insights into voltage-gated sodium channels in excitable cells: pathophysiological roles and emerging therapeutic targets. | J Recept Signal Transduct Res | 2026 | 42222937 | PubTator, text mining | PubMed |
| The Role of Micromorphology of SnS2 on the Adsorption Process of Methylene Blue. | Molecules | 2026 | 42197179 | PubTator, text mining | PubMed |
| Identification and characterization of selective inhibitors of Nav1.9 voltage dependent sodium channels. | Mol Pharmacol | 2026 | 42167068 | PubTator, text mining | PubMed |
| Polarization-State-Driven Band Engineering Enabling Mobility Bidirectional Modulation and Photodetection Enhancement in SnS2/In2Se3 Heterostructures. | ACS Appl Mater Interfaces | 2026 | 42030524 | PubTator, text mining | PubMed |
| Leveraging Signal Detection and Mendelian Randomization in Spontaneous Reporting for Post-Marketing Surveillance of Drug- Induced Amnesia. | Curr Med Chem | 2026 | 41941166 | PubTator, text mining | PubMed |
| Current and Developing Therapeutics for Dry Eye Disease: Targeting Ion Channels. | Curr Issues Mol Biol | 2026 | 41899483 | PubTator, text mining | PubMed |
| Enhanced two-dimensional ferromagnetism in van der Waals β-UTe3 monolayers. | Sci Adv | 2026 | 41880491 | PubTator, text mining | PubMed |
| Electronic Structure Reorganization in MPS3 via d-Shell-Selective Alkali Metal Doping. | Adv Sci (Weinh) | 2026 | 41873939 | PubTator, text mining | PubMed |
| Alternative splicing in voltage-gated sodium channels: mechanisms, regulatory networks and therapeutic implications. | Ann Med | 2026 | 41869747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11280/papers